CD63 and glioblastoma: Significant results were also observed for TNC+/CD81+ in newly diagnosed and relapsed patients (FC =5.9 and 6.4, respectively), as well as for TNC+/CD63+ (FC = 10.96 in newly diagnosed glioblastoma; p < 0.001) (Supporting Information Figure S2A,B and Supporting Information Table S2).